Phase II trial of ifosfamide and mesna in mixed mesodermal tumors of the uterus (A Gynecologic Oncology Group Study)-Reference-Cited by-同舟云学术

Phase II trial of ifosfamide and mesna in mixed mesodermal tumors of the uterus (A Gynecologic Oncology Group Study)

Published:1989-08 Issue:2 Volume:161 Page:309-312
ISSN:0002-9378
Container-title:American Journal of Obstetrics and Gynecology
language:en
Short-container-title:American Journal of Obstetrics and Gynecology

Author:

Sutton Gregory P.,Blessing John A.,Rosenshein Neil,Photopulos Guy,DiSaia Philip J.

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology

Reference16 articles.

1. Cyclophosphamide versus ifosfamide: final report of a randomized phase 11 trial in adult soft tissue sarcoma;Bramwell;Eur J Cancer Clin Oncol,1987

2. High dose ifosfamide in advanced osteosarcoma and soft tissue sarcoma: preliminary results of two prospective studies. Presented at the Thirteenth International Congress of Chemotherapy, Vienna, Austria, Aug. 13, 1983.

3. Design, analysis and interpretation of chemotherapy trials in gynecologic cancer;Blessing,1984

4. Sarcomas of the uterus: a clinicopathologic study of 119 patients;Kahanpaa;Obstet Gynecol,1986

5. Malignant mixed mullerian tumors of the uterus;Spanos;Cancer,1984

Cited by 131 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Endometrial carcinosarcoma;International Journal of Gynecologic Cancer;2022-12-30

2. Gynecologic Sarcomas;Holland‐Frei Cancer Medicine;2022-10-21

3. Adjuvant chemotherapy in patients with uterine carcinosarcoma: a review of clinical outcomes and considerations;Expert Opinion on Orphan Drugs;2021-12-02

4. Uterine carcinosarcoma: An overview;Critical Reviews in Oncology/Hematology;2021-07

5. Current status of the adjuvant therapy in uterine sarcoma: A literature review;World Journal of Clinical Cases;2019-07-26